Yongchen Hao, PhD; Dong Zhao, MD, PhD; Jing Liu, MD, PhD; et al.
free access
has audio
JAMA Cardiol. 2022;7(5):484-491. doi:10.1001/jamacardio.2022.0117
This quality improvement study analyzes data from a nationwide registry in China to investigate how care is provided in relation to guideline recommendations for patients hospitalized with ST-segment elevation myocardial infarction.
-
Podcast:
Performance of Guideline-Recommended Strategies for Hospitalized Patients With STEMI in China
-
Invited Commentary
Insights and Opportunities in STEMI Care in China
Hani Jneid, MD
JAMA Cardiol
-
Podcast:
Performance of Guideline-Recommended Strategies for Hospitalized Patients With STEMI in China
Fabian Laumer, MSc; Davide Di Vece, MD; Victoria L. Cammann, MD; et al.
free access
JAMA Cardiol. 2022;7(5):494-503. doi:10.1001/jamacardio.2022.0183
This cohort study assesses the utility of a fully automated and interpretable machine learning鈥揵ased framework in differentiating takotsubo syndrome from acute myocardial infarction using raw echocardiographic imaging data.
Andrea Mazzanti, MD, PhD; Deni Kukavica, MD; Alessandro Trancuccio, MD; et al.
free access
JAMA Cardiol. 2022;7(5):504-512. doi:10.1001/jamacardio.2022.0219
This cohort study investigates the long-term outcomes of patients with RYR2 catecholaminergic polymorphic ventricular tachycardia treated with 尾-blockers only and the cost to benefit ratio of implantable cardioverter defibrillator.
George D. Thornton, MBBS; Tarique A. Musa, PhD; Marzia Rigolli, PhD; et al.
free access
JAMA Cardiol. 2022;7(5):513-520. doi:10.1001/jamacardio.2022.0340
This cohort study assesses the association of left ventricular indexed stroke volume as measured by cardiac magnetic resonance (CMR) with myocardial remodeling and survival among patients with severe aortic stenosis (AS) after valve replacement.
Eric C. Svensson, MD, PhD; Aviv Madar, PhD; Catarina D. Campbell, PhD; et al.
free access
JAMA Cardiol. 2022;7(5):521-528. doi:10.1001/jamacardio.2022.0386
This genomic substudy of a randomized clinical trial assesses whether patients with clonal hematopoiesis of intermediate potential have greater cardiovascular event reduction in response to canakinumab.
Mengyao Zhou, MBBS; Shengjun Ta, MBBS; Rebecca T. Hahn, MD; et al.
free access
has multimedia
JAMA Cardiol. 2022;7(5):529-538. doi:10.1001/jamacardio.2022.0259
This cohort study assesses the safety and medium-term outcomes of percutaneous intramyocardial septal radiofrequency ablation in a large patient cohort with drug-refractory hypertrophic obstructive cardiomyopathy.
-
Video:
Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA)